Thomas Andresen

Thomas is an accomplished scientific leader and serial entrepreneur in immuno-oncology and cellular therapies. He most recently served as Chief Scientific Officer of Torque Therapeutics (now Repertoire Immune Medicines), guiding multiple immunotherapy programs from discovery through clinical development. He has founded several successful life science companies, including Repertoire Immune Medicines, Nanovi (acquired by CQ Medical), and Monta Biosciences, and served on boards such as Tidal Therapeutics (acquired by Sanofi). Thomas was the founding Director of the Institute of Health Technology at the Technical University of Denmark, leading a 500-researcher mission to deliver patient-focused innovations. He has co-authored over 200 research articles, is named on more than 50 patent applications, and is a recipient of the Elite Research Prize from the Danish Ministry of Science. He holds a background in biomedical and biological engineering.